KKR & Co Inc (NYSE: KKR) Acquires Integer Holdings Corporation (NYSE: ITGR): Key Insights into the Medical Device Acquisition

• Integer Holdings Corporation (NYSE: ITGR) is being acquired by KKR (NYSE: KKR) for approximately $5.70 billion at $127.00 per share.
• The acquisition price represents a 51.80% premium over Integer's closing price on April 29, 2026.
• An investor rights law firm, Halper Sadeh LLC, is investigating the acquisition to ensure a fair price for shareholders and compliance with federal securities laws.

Integer Holdings Corporation is a leading medical-device outsourcing company. It helps other companies develop and manufacture medical devices. On August 3, 2026, global investment firm KKR announced it will acquire Integer in a deal valued at an enterprise value of approximately $5.70 billion.

An analyst at Truist Financial (NYSE: TFC) set a new price target for Integer at $127.00. This price target directly matches the $127.00 per share all-cash offer made by KKR for the acquisition. The acquisition follows a strategic review process conducted by Integer's board of directors.

The analyst also downgraded the stock to a "Hold" rating. A "Hold" rating suggests that the stock's price is not expected to move much. This is common after an acquisition announcement, as the stock price tends to stay close to the agreed-upon purchase price until the deal is finalized.

The $127.00 per share offer is a 51.80% premium over Integer's closing price on April 29, 2026. It is also a 28.80% premium to the 30-day volume-weighted average price (VWAP) as of July 31, 2026. VWAP is the average price a stock has traded at over a period, adjusted for trading volume.

Despite the premium, an investor rights law firm, Halper Sadeh LLC, is investigating the sale. As highlighted by Business Wire, the firm is looking into whether Integer's board secured a fair price for its shareholders and followed federal securities laws during the process.